REVIEW

Chemical-only reprogramming to pluripotency

  • Behnam Ebrahimi
Expand
  • Yazd Cardiovascular Research Center, Shahid Sadoughi University of Medical Sciences, Yazd, Iran

Received date: 10 Jan 2016

Accepted date: 08 Apr 2016

Published date: 17 May 2016

Copyright

2014 Higher Education Press and Springer-Verlag Berlin Heidelberg

Abstract

Direct reprogramming technology has emerged as an outstanding technique for the generation of induced pluripotent stem cells (iPSCs) and various specialized cells directly from somatic cells of different species. Reprogramming techniques conventionally use viral vectors encoding transcription factors to induce fate conversion. However, the introduction of transgenes limits the therapeutic applications of the reprogrammed cells. To overcome safety-related concerns, small molecules offer some advantages over the existing methods for the control of gene expression and induction of cell fate conversion. Technical advances in optimizing concentrations, durations, structures, and combinations of small molecules make chemical reprogramming a safe and feasible method. This review provides a concise overview of cutting-edge findings regarding chemical-only reprogramming as one of the integration-free approaches to iPSC generation.

Cite this article

Behnam Ebrahimi . Chemical-only reprogramming to pluripotency[J]. Frontiers in Biology, 2016 , 11(2) : 75 -84 . DOI: 10.1007/s11515-016-1396-0

Acknowledgments

I would like to greatly appreciate Professor Hongkui Deng form Peking University for his kind help and professor Miguel A. Esteban from the Guangzhou Institutes of Biomedicine and Health for reading the manuscript and helpful comments.
This work was supported by Yazd Cardiovascular Research Center.
The author declares that there are no competing interests.
This manuscript is a review article and does not contain any studies with human or animal subjects.
1
Anokye-Danso F, Trivedi C M, Juhr D, Gupta M, Cui Z, Tian Y, Zhang Y, Yang W, Gruber P J, Epstein J A, Morrisey E E (2011). Highly efficient miRNA-mediated reprogramming of mouse and human somatic cells to pluripotency. Cell Stem Cell, 8(4): 376–388

DOI

2
Babos K, Ichida J K (2015). Small molecules take a big step by converting fibroblasts into neurons. Cell Stem Cell, 17(2): 127–129

DOI

3
Ban H, Nishishita N, Fusaki N, Tabata T, Saeki K, Shikamura M, Takada N, Inoue M, Hasegawa M, Kawamata S, Nishikawa S (2011). Efficient generation of transgene-free human induced pluripotent stem cells (iPSCs) by temperature-sensitive Sendai virus vectors. Proc Natl Acad Sci USA, 108(34): 14234–14239

DOI

4
Cahan P, Li H, Morris S A, Lummertz da Rocha E, Daley G Q, Collins J J (2014). Cell net: Network biology applied to stem cell engineering. Cell, 158(4): 903–915

DOI

5
Chen J K, Liu H, Liu J, Qi J, Wei B, Yang J Q, Liang H Q, Chen Y, Chen J, Wu Y R, Guo L, Zhu J Y, Zhao X J, Peng T R, Zhang Y X, Chen S, Li X J, Li D W, Wang T, Pei D Q (2013). H3K9 methylation is a barrier during somatic cell reprogramming into iPSCs. Nat Genet, 45(1): 34–U62

DOI

6
Cheng L, Gao L, Guan W, Mao J, Hu W, Qiu B, Zhao J, Yu Y, Pei G (2015). Direct conversion of astrocytes into neuronal cells by drug cocktail. Cell Res, 25(11): 1269–1272

DOI

7
Cheng L, Hu W, Qiu B, Zhao J, Yu Y, Guan W, Wang M, Yang W, Pei G (2014). Generation of neural progenitor cells by chemical cocktails and hypoxia. Cell Res, 24(6): 665–679

DOI

8
Chou B K, Gu H, Gao Y, Dowey S N, Wang Y, Shi J, Li Y, Ye Z, Cheng T, Cheng L (2015). A facile method to establish human induced pluripotent stem cells from adult blood cells under feeder-free and xeno-free culture conditions: a clinically compliant approach. Stem Cells Transl Med, 4(4): 320–332

DOI

9
Chou B K, Mali P, Huang X, Ye Z, Dowey S N, Resar L M, Zou C, Zhang Y A, Tong J, Cheng L (2011). Efficient human iPS cell derivation by a non-integrating plasmid from blood cells with unique epigenetic and gene expression signatures. Cell Res, 21(3): 518–529

DOI

10
Cyranoski D 2014. Japanese woman is first recipient of next-generation stem cells. Nature Publishing Group.

11
Davies S G, Kennewell P D, Russell A J, Seden P T, Westwood R, Wynne G M (2015). Stemistry: The control of stem cells in situ using chemistry. J Med Chem, 58(7): 2863–2894

DOI

12
Durruthy-Durruthy J, Briggs S F, Awe J, Ramathal C Y, Karumbayaram S, Lee P C, Heidmann J D, Clark A, Karakikes I, Loh K M, Wu J C, Hoffman A R, Byrne J, Reijo Pera R A, Sebastiano V (2014). Rapid and Efficient Conversion of Integration-Free Human Induced Pluripotent Stem Cells to GMP-Grade Culture Conditions. PLoS ONE, 9(4): e94231

DOI

13
Ebrahimi B (2015a). Reprogramming barriers and enhancers: strategies to enhance the efficiency and kinetics of induced pluripotency. Cell Regen (Lond), 4(1): 1–12

DOI

14
Ebrahimi B (2015b). Reprogramming of adult stem/progenitor cells into iPSCs without reprogramming factors. Journal of Medical Hypotheses and Ideas, 9(2): 99–103

DOI

15
Ebrahimi B (2016). Biological computational approaches: new hopes to improve (re)programming robustness, regenerative medicine and cancer therapeutics. Differentiation, doi: 10.1016/j.diff.2016.03.001

16
Eriksson P S, Perfilieva E, Bjork-Eriksson T, Alborn A M, Nordborg C, Peterson D A, Gage F H (1998). Neurogenesis in the adult human hippocampus. Nat Med, 4(11): 1313–1317

DOI

17
Esteban M A, Wang T, Qin B, Yang J, Qin D, Cai J, Li W, Weng Z, Chen J, Ni S, Chen K, Li Y, Liu X, Xu J, Zhang S, Li F, He W, Labuda K, Song Y, Peterbauer A, Wolbank S, Redl H, Zhong M, Cai D, Zeng L, Pei D (2010). Vitamin C enhances the generation of mouse and human induced pluripotent stem cells. Cell Stem Cell, 6(1): 71–79

DOI

18
Foster K W, Liu Z, Nail C D, Li X, Fitzgerald T J, Bailey S K, Frost A R, Louro I D, Townes T M, Paterson A J, Kudlow J E, Lobo-Ruppert S M, Ruppert J M (2005). Induction of KLF4 in basal keratinocytes blocks the proliferation-differentiation switch and initiates squamous epithelial dysplasia. Oncogene, 24(9): 1491–1500

DOI

19
Fu Y, Huang C, Xu X, Gu H, Ye Y, Jiang C, Qiu Z, Xie X (2015). Direct reprogramming of mouse fibroblasts into cardiomyocytes with chemical cocktails. Cell Res, 25(9): 1013–1024

DOI

20
Fusaki N, Ban H, Nishiyama A, Saeki K, Hasegawa M (2009). Efficient induction of transgene-free human pluripotent stem cells using a vector based on Sendai virus, an RNA virus that does not integrate into the host genome. Proc Jpn Acad, Ser B, Phys Biol Sci, 85(8): 348–362

DOI

21
Goh P A, Caxaria S, Casper C, Rosales C, Warner T T, Coffey P J, Nathwani A C (2013). A systematic evaluation of integration free reprogramming methods for deriving clinically relevant patient specific induced pluripotent stem (iPS) cells. PLoS ONE, 8(11): e81622

DOI

22
González F, Boué S, Belmonte J C I (2011). Methods for making induced pluripotent stem cells: reprogramming à la carte. Nat Rev Genet, 12(4): 231–242

DOI

23
He S, Guo Y, Zhang Y, Li Y, Feng C, Li X, Lin L, Guo L, Wang H, Liu C, Zheng Y, Luo C, Liu Q, Wang F, Sun H, Liang L, Li L, Su H, Chen J, Pei D, Zheng H (2015). Reprogramming somatic cells to cells with neuronal characteristics by defined medium both in vitro and in vivo. Cell Regen (Lond), 4(1): 1–9

DOI

24
Higuchi A, Ling Q D, Kumar S S, Munusamy M A, Alarfaj A A, Chang Y, Kao S H, Lin K C, Wang H C, Umezawa A (2015). Generation of pluripotent stem cells without the use of genetic material. Lab Invest, 95(1): 26–42

DOI

25
Hochedlinger K, Yamada Y, Beard C, Jaenisch R (2005). Ectopic expression of Oct-4 blocks progenitor-cell differentiation and causes dysplasia in epithelial tissues. Cell, 121(3): 465–477

DOI

26
Hou P, Li Y, Zhang X, Liu C, Guan J, Li H, Zhao T, Ye J, Yang W, Liu K, Ge J, Xu J, Zhang Q, Zhao Y, Deng H (2013). Pluripotent stem cells induced from mouse somatic cells by small-molecule compounds. Science, 341(6146): 651–654

DOI

27
Hu W, Qiu B, Guan W, Wang Q, Wang M, Li W, Gao L, Shen L, Huang Y, Xie G, Zhao H, Jin Y, Tang B, Yu Y, Zhao J, Pei G (2015). Direct conversion of normal and alzheimer’s disease human fibroblasts into neuronal cells by small molecules. Cell Stem Cell, 17(2): 204–212

DOI

28
Ichida J K, Blanchard J, Lam K, Son E Y, Chung J E, Egli D, Loh K M, Carter A C, Di Giorgio F P, Koszka K, Huangfu D, Akutsu H, Liu D R, Rubin L L, Eggan K (2009). A small-molecule inhibitor of tgf-Beta signaling replaces sox2 in reprogramming by inducing nanog. Cell Stem Cell, 5(5): 491–503

DOI

29
Jung D W, Kim W H, Williams D R (2014). Reprogram or reboot: small molecule approaches for the production of induced pluripotent stem cells and direct cell reprogramming. ACS Chem Biol, 9(1): 80–95

DOI

30
Kaji K, Norrby K, Paca A, Mileikovsky M, Mohseni P, Woltjen K (2009). Virus-free induction of pluripotency and subsequent excision of reprogramming factors. Nature, 458(7239): 771–775

DOI

31
Kim D, Kim C H, Moon J I, Chung Y G, Chang M Y, Han B S, Ko S, Yang E, Cha K Y, Lanza R, Kim K S (2009). Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins. Cell Stem Cell, 4(6): 472–476

DOI

32
Koyanagi-Aoi M, Ohnuki M, Takahashi K, Okita K, Noma H, Sawamura Y, Teramoto I, Narita M, Sato Y, Ichisaka T, Amano N, Watanabe A, Morizane A, Yamada Y, Sato T, Takahashi J, Yamanaka S (2013). Differentiation-defective phenotypes revealed by large-scale analyses of human pluripotent stem cells. Proc Natl Acad Sci USA, 110(51): 20569–20574

DOI

33
Lee A S, Tang C, Rao M S, Weissman I L, Wu J C (2013). Tumorigenicity as a clinical hurdle for pluripotent stem cell therapies. Nat Med, 19(8): 998–1004

DOI

34
Lee J, Sayed N, Hunter A, Au K F, Wong W H, Mocarski E S, Pera R R, Yakubov E, Cooke J P (2012). Activation of Innate Immunity Is Required for Efficient Nuclear Reprogramming. Cell, 151(3): 547–558

DOI

35
Li W, Jiang K, Ding S (2012a). Concise review: A chemical approach to control cell fate and function. Stem Cells, 30(1): 61–68

DOI

36
Li W, Jiang K, Wei W, Shi Y, Ding S (2013a). Chemical approaches to studying stem cell biology. Cell Res, 23(1): 81–91

DOI

37
Li W, Li K, Wei W, Ding S (2013b). Chemical approaches to stem cell biology and therapeutics. Cell Stem Cell, 13(3): 270–283

DOI

38
Li W, Tian E, Chen Z X, Sun G, Ye P, Yang S, Lu D, Xie J, Ho T V, Tsark W M, Wang C, Horne D A, Riggs A D, Yip M L, Shi Y (2012b). Identification of Oct4-activating compounds that enhance reprogramming efficiency. Proc Natl Acad Sci USA, 109(51): 20853–20858

DOI

39
Li X, Zuo X, Jing J, Ma Y, Wang J, Liu D, Zhu J, Du X, Xiong L, Du Y, Xu J, Xiao X, Wang J, Chai Z, Zhao Y, Deng H (2015). Small-molecule-driven direct reprogramming of mouse fibroblasts into functional n<?Pub Caret?>eurons. Cell Stem Cell, 17(2): 195–203

DOI

40
Li Y, Zhang Q, Yin X, Yang W, Du Y, Hou P, Ge J, Liu C, Zhang W, Zhang X, Wu Y, Li H, Liu K, Wu C, Song Z, Zhao Y, Shi Y, Deng H (2011). Generation of iPSCs from mouse fibroblasts with a single gene, Oct4, and small molecules. Cell Res, 21(1): 196–204

DOI

41
Lin T, Ambasudhan R, Yuan X, Li W, Hilcove S, Abujarour R, Lin X, Hahm H S, Hao E, Hayek A, Ding S (2009). A chemical platform for improved induction of human iPSCs. Nat Methods, 6(11): 805–808

DOI

42
Lin T, Wu S (2015). Reprogramming with Small Molecules instead of Exogenous Transcription Factors. Stem Cells Int, 2015: 794632

DOI

43
Long Y, Wang M, Gu H, Xie X (2015). Bromodeoxyuridine promotes full-chemical induction of mouse pluripotent stem cells. Cell Res, 25(10): 1171–1174

DOI

44
Lu X, Zhao T (2013). Clinical Therapy Using iPSCs: Hopes and Challenges. Genomics Proteomics Bioinformatics, 11(5): 294–298

DOI

45
Ma H, Morey R, O'Neil R C, He Y, Daughtry B, Schultz M D, Hariharan M, Nery J R, Castanon R, Sabatini K, Thiagarajan R D, Tachibana M, Kang E, Tippner-Hedges R, Ahmed R, Gutierrez N M, Van Dyken C, Polat A, Sugawara A, Sparman M, Gokhale S, Amato P, Wolf P, Ecker D Jr, Laurent L C, Mitalipov S (2014). Abnormalities in human pluripotent cells due to reprogramming mechanisms. Nature, 511: 177–183

DOI

46
Masuda S, Wu J, Hishida T, Pandian G N, Sugiyama H, Izpisua Belmonte J C (2013). Chemically induced pluripotent stem cells (CiPSCs): a transgene-free approach. J Mol Cell Biol, 5(5): 354–355

DOI

47
Morris S A, Cahan P, Li H, Zhao A M, San Roman A K, Shivdasani R A, Collins J J, Daley G Q (2014). Dissecting Engineered Cell Types and Enhancing Cell Fate Conversion via CellNet. Cell, 158(4): 889–902

DOI

48
Ohnishi K, Semi K, Yamamoto T, Shimizu M, Tanaka A, Mitsunaga K, Okita K, Osafune K, Arioka Y, Maeda T, Soejima H, Moriwaki H, Yamanaka S, Woltjen K, Yamada Y (2014). Premature Termination of Reprogramming In Vivo Leads to Cancer Development through Altered Epigenetic Regulation. Cell, 156(4): 663–677

DOI

49
Okano H, Nakamura M, Yoshida K, Okada Y, Tsuji O, Nori S, Ikeda E, Yamanaka S, Miura K (2013). Steps toward safe cell therapy using induced pluripotent stem cells. Circ Res, 112(3): 523–533

DOI

50
Okita K, Ichisaka T, Yamanaka S (2007). Generation of germline-competent induced pluripotent stem cells. Nature, 448(7151): 313–317

DOI

51
Okita K, Nakagawa M, Hyenjong H, Ichisaka T, Yamanaka S (2008). Generation of mouse induced pluripotent stem cells without viral vectors. Science, 322(5903): 949–953

DOI

52
Okita K, Yamakawa T, Matsumura Y, Sato Y, Amano N, Watanabe A, Goshima N, Yamanaka S (2013). An efficient nonviral method to generate integration-free human-induced pluripotent stem cells from cord blood and peripheral blood cells. Stem Cells, 31(3): 458–466

DOI

53
Okita K, Yamanaka S (2011). Induced pluripotent stem cells: opportunities and challenges. Philos Trans R Soc Lond B Biol Sci, 366(1575): 2198–2207

DOI

54
Onder T T, Kara N, Cherry A, Sinha A U, Zhu N, Bernt K M, Cahan P, Marcarci B O, Unternaehrer J, Gupta P B, Lander E S, Armstrong S A, Daley G Q (2012). Chromatin-modifying enzymes as modulators of reprogramming. Nature, 483(7391): 598–602

DOI

55
Pandian G N, Nakano Y, Sato S, Morinaga H, Bando T, Nagase H, Sugiyama H (2012). A synthetic small molecule for rapid induction of multiple pluripotency genes in mouse embryonic fibroblasts. Sci Rep, 2: 544

DOI

56
Pennarossa G, Maffei S, Campagnol M, Tarantini L, Gandolfi F, Brevini T A (2013). Brief demethylation step allows the conversion of adult human skin fibroblasts into insulin-secreting cells. Proc Natl Acad Sci USA, 110(22): 8948–8953

DOI

57
Piao Y, Hung S S, Lim S Y, Wong R C, Ko M S (2014). Efficient generation of integration-free human induced pluripotent stem cells from keratinocytes by simple transfection of episomal vectors. Stem Cells Transl Med, 3(7): 787–791

DOI

58
Sayed N, Wong W T, Ospino F, Meng S, Lee J, Jha A, Dexheimer P, Aronow B J, Cooke J P (2015). Transdifferentiation of human fibroblasts to endothelial cells: role of innate immunity. Circulation, 131(3): 300–309

DOI

59
Schlaeger T M, Daheron L, Brickler T R, Entwisle S, Chan K, Cianci A, DeVine A, Ettenger A, Fitzgerald K, Godfrey M, Gupta D, McPherson J, Malwadkar P, Gupta M, Bell B, Doi A, Jung N, Li X, Lynes M S, Brookes E, Cherry A B C, Demirbas D, Tsankov A M, Zon L I, Rubin L L, Feinberg A P, Meissner A, Cowan C A, Daley G Q (2015). A comparison of non-integrating reprogramming methods. Nat Biotechnol, 33(1): 58–63

DOI

60
Shi Y, Desponts C, Do J T, Hahm H S, Scholer H R, Ding S (2008). Induction of pluripotent stem cells from mouse embryonic fibroblasts by Oct4 and Klf4 with small-molecule compounds. Cell Stem Cell, 3(5): 568–574

DOI

61
Shu J, Wu C, Wu Y, Li Z, Shao S, Zhao W, Tang X, Yang H, Shen L, Zuo X, Yang W, Shi Y, Chi X, Zhang H, Gao G, Shu Y, Yuan K, He W, Tang C, Zhao Y, Deng H (2013). Induction of pluripotency in mouse somatic cells with lineage specifiers. Cell, 153(5): 963–975

DOI

62
Silva M, Daheron L, Hurley H, Bure K, Barker R, Carr A J, Williams D, Kim H W, French A, Coffey P J, Cooper-White J J, Reeve B, Rao M, Snyder E Y, Ng K S, Mead B E, Smith J A, Karp J M, Brindley D A, Wall I (2015). Generating iPSCs: Translating Cell Reprogramming Science into Scalable and Robust Biomanufacturing Strategies. Cell Stem Cell, 16(1): 13–17

DOI

63
Soldner F, Hockemeyer D, Beard C, Gao Q, Bell G W, Cook E G, Hargus G, Blak A, Cooper O, Mitalipova M, Isacson O, Jaenisch R (2009). Parkinson's disease patient-derived induced pluripotent stem cells free of viral reprogramming factors. Cell, 136(5): 964–977

DOI

64
Stadtfeld M, Apostolou E, Ferrari F, Choi J, Walsh R M, Chen T, Ooi S S, Kim S Y, Bestor T H, Shioda T, Park P J, Hochedlinger K, (2012). Ascorbic acid prevents loss of Dlk1-Dio3 imprinting and facilitates generation of all-iPS cell mice from terminally differentiated B cells. Nat Genet, 44: 398–405, S391–392

65
Stadtfeld M, Nagaya M, Utikal J, Weir G, Hochedlinger K (2008). Induced pluripotent stem cells generated without viral integration. Science, 322(5903): 945–949

DOI

66
Su J B, Pei D Q, Qin B M (2013). Roles of small molecules in somatic cell reprogramming. Acta Pharmacol Sin, 34(6): 719–724

DOI

67
Sugiura M, Kasama Y, Araki R, Hoki Y, Sunayama M, Uda M, Nakamura M, Ando S, Abe M (2014). Induced Pluripotent Stem Cell Generation-Associated Point Mutations Arise during the Initial Stages of the Conversion of These Cells. Stem Cell Rep, 2(1): 52–63

DOI

68
Takahashi K, Tanabe K, Ohnuki M, Narita M, Sasaki A, Yamamoto M, Nakamura M, Sutou K, Osafune K, Yamanaka S (2014). Induction of pluripotency in human somatic cells via a transient state resembling primitive streak-like mesendoderm. Nat Commun, 5: 3678

DOI

69
Takahashi K, Yamanaka S (2006). Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell, 126(4): 663–676

DOI

70
Tomaru Y, Hasegawa R, Suzuki T, Sato T, Kubosaki A, Suzuki M, Kawaji H, Forrest A R R, Hayashizaki Y, Consortium F, Shin J W, Suzuki H (2014). A transient disruption of fibroblastic transcriptional regulatory network facilitates trans-differentiation. Nucleic Acids Res, 42(14): 8905–8913

DOI

71
Valamehr B, Robinson M, Abujarour R, Rezner B, Vranceanu F, Le T, Medcalf A, Lee T T, Fitch M, Robbins D, Flynn P (2014). Platform for Induction and Maintenance of Transgene-free hiPSCs Resembling Ground State Pluripotent Stem Cells. Stem Cell Rep, 2(3): 366–381

DOI

72
Vidal S E, Amlani B, Chen T, Tsirigos A, Stadtfeld M (2014). Combinatorial Modulation of Signaling Pathways Reveals Cell-Type-Specific Requirements for Highly Efficient and Synchronous iPSC Reprogramming. Stem Cell Rep, 3(4): 574–584

DOI

73
Wang T, Chen K, Zeng X, Yang J, Wu Y, Shi X, Qin B, Zeng L, Esteban M A, Pan G, Pei D (2011). The histone demethylases Jhdm1a/1b enhance somatic cell reprogramming in a vitamin-C-dependent manner. Cell Stem Cell, 9(6): 575–587

DOI

74
Warren L, Manos P D, Ahfeldt T, Loh Y H, Li H, Lau F, Ebina W, Mandal P K, Smith Z D, Meissner A, Daley G Q, Brack A S, Collins J J, Cowan C, Schlaeger T M, Rossi D J (2010). Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. Cell Stem Cell, 7(5): 618– 630

DOI

75
Woltjen K, Michael I P, Mohseni P, Desai R, Mileikovsky M, Hamalainen R, Cowling R, Wang W, Liu P, Gertsenstein M, Kaji K, Sung H K, Nagy A (2009). piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells. Nature, 458(7239): 766–770

DOI

76
Xu J, Du Y, Deng H (2015). Direct Lineage Reprogramming: Strategies, Mechanisms, and Applications. Cell Stem Cell, 16(2): 119–134

DOI

77
Ye J, Ge J, Zhang X, Cheng L, Zhang Z, He S, Wang Y, Lin H, Yang W, Liu J, Zhao Y, Deng H (2016). Pluripotent stem cells induced from mouse neural stem cells and small intestinal epithelial cells by small molecule compounds. Cell Res, 26(1): 34–45

DOI

78
Yu C, Liu K, Tang S, Ding S (2014). Chemical approaches to cell reprogramming. Curr Opin Genet Dev, 28: 50–56

DOI

79
Yu J, Chau K F, Vodyanik M A, Jiang J, Jiang Y (2011). Efficient feeder-free episomal reprogramming with small molecules. PLoS ONE, 6(3): e17557

DOI

80
Yu J, Hu K, Smuga-Otto K, Tian S, Stewart R, Slukvin I I, Thomson J A (2009). Human induced pluripotent stem cells free of vector and transgene sequences. Science, 324(5928): 797–801

DOI

81
Zhang L, Yin J C, Yeh H, Ma N X, Lee G, Chen X A, Wang Y, Lin L, Chen L, Jin P, Wu G Y, Chen G (2015). Small Molecules Efficiently Reprogram Human Astroglial Cells into Functional Neurons. Cell Stem Cell, 17(6): 735–747

DOI

82
Zhao Y, Zhao T, Guan J, Zhang X, Fu Y, Ye J, Zhu J, Meng G, Ge J, Yang S, Cheng L, Du Y, Zhao C, Wang T, Su L, Yang W, Deng H (2015). A XEN-like State Bridges Somatic Cells to Pluripotency during Chemical Reprogramming. Cell, 163(7): 1678–1691

DOI

83
Zhou H, Wu S, Joo J Y, Zhu S, Han D W, Lin T, Trauger S, Bien G, Yao S, Zhu Y, Siuzdak G, Scholer H R, Duan L, Ding S (2009). Generation of induced pluripotent stem cells using recombinant proteins. Cell Stem Cell, 4(5): 381–384

DOI

84
Zhou Y y, Zeng F (2013). Integration-free Methods for Generating Induced Pluripotent Stem Cells. Genomics Proteomics Bioinformatics, 11(5): 284–287

DOI

85
Zhu S, Li W, Zhou H, Wei W, Ambasudhan R, Lin T, Kim J, Zhang K, Ding S (2010). Reprogramming of human primary somatic cells by OCT4 and chemical compounds. Cell Stem Cell, 7(6): 651–655

DOI

Outlines

/